Maxim Kosov, MD, PhD

Articles by Maxim Kosov, MD, PhD

Interexpert Agreement on Adverse Events’ Evaluation

ByMaxim Belotserkovskiy, MD,Maxim Kosov, MD, PhD,Alexey Maximovich,Maria Cecilia Dignani, MD,John Riefler, MD,Eric Batson MD, PhD

August 1st 2016

Applied Clinical Trials

Study measures the differing judgment levels between clinical investigators and drug safety experts.

Interexpert Agreement on Adverse Events’ Evaluation

ByMaxim Belotserkovskiy, MD,Maxim Kosov, MD, PhD,Alexey Maximovich,Maria Cecilia Dignani, MD,John Riefler, MD,Eric Batson MD, PhD

April 21st 2016

Drug safety surveillance, a core focus of clinical trials, can be influenced by subjective judgement, as this analysis of differing expert assessments of adverse drug reactions-and the reasons why-shows.

Latest Updated Articles

Interexpert Agreement on Adverse Events’ Evaluation
April 21st 2016
Interexpert Agreement on Adverse Events’ Evaluation
August 1st 2016

Maxim Kosov, MD, PhD

Articles by Maxim Kosov, MD, PhD

Interexpert Agreement on Adverse Events’ Evaluation

Interexpert Agreement on Adverse Events’ Evaluation

Latest Updated Articles

Trending on Applied Clinical Trials Online

Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology

Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease

Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect

Where AI Governance in Clinical Development Falls Short

ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act